Impact BioMedical, INC. (IBO) Debt Components
- 2025-09-30: Notes Payable, CurrentUSD $22.88M; Debt, CurrentUSD (m); Notes PayableUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-09-01: Notes Payable, CurrentUSD (m); Debt, CurrentUSD (m); Notes PayableUSD $14.99M; Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-06-30: Notes Payable, CurrentUSD $22.35M; Debt, CurrentUSD (m); Notes PayableUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-03-31: Notes Payable, CurrentUSD $9.14M; Debt, CurrentUSD (m); Notes PayableUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
Impact BioMedical, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Debt, Current USD | Notes Payable USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Debt Instrument, Face Amount USD | Long-term Debt, Fair Value USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Periodic Payment USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $22.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-01 | (m) | (m) | $14.99M | (m) | (m) | (m) | $1.81M | (m) | (m) | (m) |
| 2025-06-30 | $22.35M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $9.14M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $8.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $12.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $35.00K | (m) | (m) | $35.00K | $781.00K | $12.86M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $13.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 0.50% | (m) |
| 2024-03-31 | $12.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 50.00% | (m) |
| 2023-12-31 | $12.07M | (m) | $12.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 50.00% | (m) |
| 2023-09-30 | (m) | $11.90M | (m) | (m) | (m) | (m) | (m) | $34.70M | (m) | (m) |
| 2023-09-30 | $11.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $11.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $9.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-02-19 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6.50% | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 0.50% | $126.38K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |